Eric J Wyble, MD | |
1133 45th Ave, Gulfport, MS 39501-2564 | |
(228) 865-7299 | |
Not Available |
Full Name | Eric J Wyble |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 42 Years |
Location | 1133 45th Ave, Gulfport, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790751337 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 12046 (Mississippi) | Primary |
Entity Name | Gulf Coast Plastic Surgery |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093780959 PECOS PAC ID: 5092807610 Enrollment ID: O20070827000553 |
News Archive
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines in China, today announced financial results for the three months and fiscal year ended October 31, 2011.
Registration is now open for Disease Models & Mechanisms' one-day symposium entitled Protein-Folding Diseases: Models & Mechanisms.
In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Eric J Wyble, MD 1133 45th Ave, Gulfport, MS 39501 Ph: (228) 865-7299 | Eric J Wyble, MD 1133 45th Ave, Gulfport, MS 39501-2564 Ph: (228) 865-7299 |
News Archive
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines in China, today announced financial results for the three months and fiscal year ended October 31, 2011.
Registration is now open for Disease Models & Mechanisms' one-day symposium entitled Protein-Folding Diseases: Models & Mechanisms.
In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
› Verified 7 days ago